Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder

被引：0
|
作者：
Ashish P. Thakrar
Tanya J. Uritsky
Cara Christopher
Anna Winston
Kaitlin Ronning
Anna Lee Sigueza
Anne Caputo
Rachel McFadden
Jennifer M. Olenik
Jeanmarie Perrone
M. Kit Delgado
Margaret Lowenstein
Peggy Compton
机构：
[1] University of Pennsylvania,National Clinician Scholars Program at the Corporal Michael J. Crescenz Veterans Affairs Medical Center
[2] University of Pennsylvania,Center for Addiction Medicine & Policy
[3] Hospital of the University of Pennsylvania,Department of Pharmacy
[4] University of Pennsylvania,Department of Medicine, Perelman School of Medicine
[5] University of Pennsylvania,School of Nursing
[6] University of Pennsylvania,Department of Emergency Medicine, Perelman School of Medicine
[7] Hospital of the University of Pennsylvania,Department of Emergency Medicine
来源：
Addiction Science & Clinical Practice | / 18卷
关键词：
Opioid use disorder; Hospitalized patients; Fentanyl; Opioid agonist treatment; Short-acting opioids; Methadone; Buprenorphine; Opioid withdrawal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
    Thakrar, Ashish P.
    Uritsky, Tanya J.
    Christopher, Cara
    Winston, Anna
    Ronning, Kaitlin
    Sigueza, Anna Lee
    Caputo, Anne
    McFadden, Rachel
    Olenik, Jennifer M.
    Perrone, Jeanmarie
    Delgado, M. Kit
    Lowenstein, Margaret
    Compton, Peggy
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2023, 18 (01)
  • [2] Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
    Nordeck, Courtney D.
    Welsh, Christopher
    Schwartz, Robert P.
    Mitchell, Shannon Gwin
    O'Grady, Kevin E.
    Gryczynski, Jan
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2022, 2
  • [3] Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service
    Nordeck, Courtney D.
    Welsh, Christopher
    Schwartz, Robert P.
    Mitchell, Shannon Gwin
    O'Grady, Kevin E.
    Gryczynski, Jan
    OPTICS CONTINUUM, 2022, 2
  • [4] Treatment of Inpatient Opioid Withdrawal with Short-Acting Full Agonist Opioids at a Safety-Net Hospital
    Steiner, Gabriela
    Suen, Leslie W.
    Martin, Marlene
    Skinner, Sasha
    Crouch, Pierre
    Nguyen, Oanh K.
    Slown, Kristin
    Logan, Alexander
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2025,
  • [5] Opioid Agonist Treatment for Opioid Use Disorder patients in Central Asia
    Michels, Ingo Ilja
    Stover, Heino
    Aizberg, Oleg
    Boltaev, Azizbek
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2021, 23 (01) : 33 - 46
  • [6] Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients
    Herscher, Michael
    Fine, Matthew
    Navalurkar, Reema
    Hirt, Leeza
    Wang, Linda
    MEDICAL CLINICS OF NORTH AMERICA, 2020, 104 (04) : 695 - +
  • [7] The Impact of Chronic Pain on Opioid Use Disorder Treatment Outcomes
    MacLean, R. Ross
    Spinola, Suzanne
    Garcia-Vassallo, Gabriella
    Sofuoglu, Mehmet
    CURRENT ADDICTION REPORTS, 2021, 8 (01) : 100 - 108
  • [8] The Impact of Chronic Pain on Opioid Use Disorder Treatment Outcomes
    R. Ross MacLean
    Suzanne Spinola
    Gabriella Garcia-Vassallo
    Mehmet Sofuoglu
    Current Addiction Reports, 2021, 8 : 100 - 108
  • [9] Nonmedical use of gabapentin and opioid agonist medications in treatment-seeking individuals with opioid use disorder
    Ellis, Matthew S.
    Buttram, Mance E.
    Kasper, Zachary A.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 234
  • [10] Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients
    Acharya, Mahip
    Hayes, Corey J.
    Li, Chenghui
    Painter, Jacob T.
    Dayer, Lindsey
    Martin, Bradley C.
    CLINICAL JOURNAL OF PAIN, 2023, 39 (03) : 107 - 118
12345